Search Results - "Cincotta, Stephanie L."

Emerging role of sertindole in the management of schizophrenia by Cincotta, Stephanie L, Rodefer, Joshua S

“…The atypical antipsychotic sertindole is a phenylindole-derived compound that has affinity for and functions as an antagonist at a number of receptor systems,…”
Get full text

Hospital use of antipsychotic drugs: polytherapy by Centorrino, Franca, Cincotta, Stephanie L, Talamo, Alessandra, Fogarty, Kate V, Guzzetta, Francesca, Saadeh, Mark G, Salvatore, Paola, Baldessarini, Ross J

“…Abstract Objective Growing acceptance of new psychotropic drugs encouraged a survey of current use of antipsychotic drugs alone and in combinations, with…”
Get full text

An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder by Centorrino, Franca, Meyers, Adam L., Ahl, Jonna, Cincotta, Stephanie L., Zun, Leslie, Gulliver, Angela H., Kinon, Bruce J., Houston, John P.

“…Objective To determine the effect of intramuscular (IM) olanzapine in severely agitated patients. Methods This was an open‐label multicenter 1‐week…”
Get full text

Use of combinations of antipsychotics: McLean Hospital inpatients, 2002 by Centorrino, Franca, Fogarty, Kate V., Sani, Gabriele, Salvatore, Paola, Cincotta, Stephanie L., Hennen, John, Guzzetta, Francesca, Talamo, Alessandra, Saadeh, Mark G., Baldessarini, Ross J.

“…Background The empirical use of combinations of antipsychotic agents appears to be increasing with little research support for the relative efficacy, safety or…”
Get full text

Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients by Centorrino, Franca, Fogarty, Kate V, Cimbolli, Paola, Salvatore, Paola, Thompson, Terri-Ann, Sani, Gabriele, Cincotta, Stephanie L, Baldessarini, Ross J

“…Aripiprazole is the first dopamine D2 receptor partial-agonist approved for treatment of schizophrenia. Its apparently benign adverse-effect profile encourages…”
Get full text

Selective nicotinic acetylcholine receptor agonists: potential therapies for neuropsychiatric disorders with cognitive dysfunction by Cincotta, Stephaine L, Yorek, Matthew S, Moschak, Travis M, Lewis, Samantha R, Rodefer, Joshua S

“…Cognitive impairment is one of the most functionally debilitating aspects of neuropsychiatric and neurodegenerative disorders, such as schizophrenia and…”
Get more information